NEW YORK (GenomeWeb) – Leaders of the British Columbia Cancer Agency's ongoing Personalized OncoGenomics (POG) clinical trial have published data on the results from the first 100 patients recruited to the study, in which researchers are sequencing the whole genomes and transcriptomes of participants with advanced cancer to inform personalized treatment.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.